跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
HEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLE
Approved
STANDARD
HEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLE
Gilead Sciences Ireland Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 26, 2021
Approval ID
77f6b06a3ebff37d
Company
Gilead Sciences Ireland Unlimited Company
Type
Standard
Approval Details
Approval Id
77f6b06a3ebff37d
Drug Cima Aemps Name
HEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLE
Register Number
1201446001
Holder Company Name
Gilead Sciences Ireland Unlimited Company
Marketing Company Name
Gilead Sciences S.L.
Holder Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Authorization Date
2021-10-26
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Dose
2 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Gilead Sciences Ireland Unlimited Company
Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
GILEAD SCIENCES IRELAND UNLIMITED COMPANY
Country Name
Ireland
City Name
carrigtwohill,country_ie
Address
Ida Business & Technology Park
Active Ingredients
BULEVIRTIDA ACETATO
2,022 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 26, 2021
Approval ID
77f6b06a3ebff37d
Type
Standard
Back to CIMA-AEMPS Approvals